• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人血清中替代补体途径调控中β1H球蛋白和C3b灭活剂的要求。

Requirements for beta1H globulin and C3b inactivator in the control of the alternative complement pathway in human serum.

作者信息

Whaley K, Thompson R A

出版信息

Immunology. 1978 Dec;35(6):1045-9.

PMID:83964
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1457447/
Abstract

Using beta1H-depleted and C3b inactivator (C3b1NA)-deficient sera we have investigated the regulatory roles of beta1H and C3bINA in the turnover of the alternative pathway. Spontaneous turnover of C3 and factor B occurred in both beta1H-depleted and C3bINA-deficient sera. In neither case was C3d generated. Prevention of activation could be achieved by the addition of the missing protein, but not by increasing the concentration of the remaining protein. Thus both beta1H and C3bINA must be present simultaneously to prevent spontaneous activation of the alternative pathway.

摘要

利用缺乏β1H和C3b灭活剂(C3bINA)的血清,我们研究了β1H和C3bINA在替代途径转换中的调节作用。在缺乏β1H和C3bINA的血清中均发生了C3和B因子的自发转换。两种情况下均未产生C3d。添加缺失的蛋白可实现激活的预防,但增加剩余蛋白的浓度则无法实现。因此,β1H和C3bINA必须同时存在才能防止替代途径的自发激活。

相似文献

1
Requirements for beta1H globulin and C3b inactivator in the control of the alternative complement pathway in human serum.人血清中替代补体途径调控中β1H球蛋白和C3b灭活剂的要求。
Immunology. 1978 Dec;35(6):1045-9.
2
Modulation of the properdin amplification loop in membranoproliferative and other forms of glomerulonephritis.膜增生性肾小球肾炎及其他形式肾小球肾炎中备解素放大环的调节
Clin Exp Immunol. 1979 Jan;35(1):101-6.
3
Relative importance of C3b inactivator and beta 1H globulin in the modulation of the properdin amplification loop in systemic lupus erythematosus.C3b灭活因子和β1H球蛋白在系统性红斑狼疮中对备解素放大环调节作用的相对重要性
Clin Exp Immunol. 1979 Jun;36(3):408-14.
4
Alternative pathway complement activation in rheumatoid arthritis.类风湿关节炎中的替代途径补体激活
J Rheumatol. 1980 Jul-Aug;7(4):453-60.
5
Complement C3 convertase: cell surface restriction of beta1H control and generation of restriction on neuraminidase-treated cells.补体C3转化酶:β1H调控的细胞表面限制及神经氨酸酶处理细胞上限制的产生
Proc Natl Acad Sci U S A. 1978 May;75(5):2416-20. doi: 10.1073/pnas.75.5.2416.
6
Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution.人补体C3b灭活因子:溶液中C3b和C4b裂解对血清蛋白β1H绝对需求的分离、特性鉴定及证明
J Exp Med. 1977 Jul 1;146(1):257-70. doi: 10.1084/jem.146.1.257.
7
Pathways of complement activation in membranoproliferative glomerulonephritis and allograft rejection.膜增生性肾小球肾炎和同种异体移植排斥反应中补体激活途径。
Transplant Proc. 1977 Mar;9(1):729-39.
8
The role of immunoglobulins in alternative pathway activation by zymosan. II. The effect of IgG on the kinetics of the alternative pathway.免疫球蛋白在酵母聚糖激活替代途径中的作用。II. IgG对替代途径动力学的影响。
J Immunol. 1981 Jan;126(1):11-5.
9
Prevention of immune precipitation by purified components of the alternative pathway.通过替代途径的纯化成分预防免疫沉淀。
Clin Exp Immunol. 1985 Apr;60(1):169-77.
10
Effect of gangliosides on activation of the alternative pathway of human complement.神经节苷脂对人补体替代途径激活的影响。
J Immunol. 1988 Mar 1;140(5):1581-7.

引用本文的文献

1
Genetic and environmental factors influencing the human factor H plasma levels.影响人血浆因子H水平的遗传和环境因素。
Immunogenetics. 2004 May;56(2):77-82. doi: 10.1007/s00251-004-0660-7. Epub 2004 Apr 30.
2
C3b inactivator deficiency with immune complex manifestations.伴有免疫复合物表现的C3b灭活因子缺乏症。
Clin Exp Immunol. 1982 Jan;47(1):197-205.
3
Complement activation in chronic liver disease.慢性肝病中的补体激活
Clin Exp Immunol. 1982 Mar;47(3):548-54.
4
Hypocomplementaemia due to a genetic deficiency of beta 1H globulin.由于β1H球蛋白基因缺陷导致的补体血症。
Clin Exp Immunol. 1981 Oct;46(1):110-9.
5
Biosynthesis of the complement components and the regulatory proteins of the alternative complement pathway by human peripheral blood monocytes.人外周血单核细胞对补体成分及替代补体途径调节蛋白的生物合成
J Exp Med. 1980 Mar 1;151(3):501-16. doi: 10.1084/jem.151.3.501.
6
The quest for an intrinsic C3 activating factor in human glomerular disease.对人类肾小球疾病中一种内源性C3激活因子的探索。
Surv Immunol Res. 1982;1(2):191-8. doi: 10.1007/BF02918345.
7
Evaluation of alternative pathway and factor B haemolytic activities in patients with systemic lupus erythematosus: correlations with the alternative pathway regulatory proteins.系统性红斑狼疮患者替代途径及B因子溶血活性的评估:与替代途径调节蛋白的相关性
Clin Exp Immunol. 1980 Dec;42(3):495-505.
8
Combined homozygous factor H and heterozygous C2 deficiency in an Italian family.
J Clin Immunol. 1988 Jan;8(1):50-6. doi: 10.1007/BF00915156.
9
CNBr cleavage of the light chain of human complement factor I and alignment of the fragments.人补体因子I轻链的溴化氰裂解及片段比对
Biochem J. 1986 Jan 15;233(2):339-45. doi: 10.1042/bj2330339.
10
Relative importance of C3b inactivator and beta 1H globulin in the modulation of the properdin amplification loop in systemic lupus erythematosus.C3b灭活因子和β1H球蛋白在系统性红斑狼疮中对备解素放大环调节作用的相对重要性
Clin Exp Immunol. 1979 Jun;36(3):408-14.

本文引用的文献

1
ISOLATION OF BETA IF-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENT.从人血清中分离β-免疫球蛋白并将其鉴定为补体的第五成分。
J Exp Med. 1965 Aug 1;122(2):277-98. doi: 10.1084/jem.122.2.277.
2
The immune-adherence phenomenon; an immunologically specific reaction between microorganisms and erythrocytes leading to enhanced phagocytosis.免疫黏附现象;微生物与红细胞之间的免疫特异性反应,导致吞噬作用增强。
Science. 1953 Dec 18;118(3077):733-7. doi: 10.1126/science.118.3077.733.
3
C3 inactivator of man. I. Hemolytic measurement by the inactivation of cell-bound C3.人C3灭活剂。I. 通过细胞结合C3的灭活进行溶血测定。
J Immunol. 1969 Mar;102(3):533-43.
4
Complement dependent immune phagocytosis. I. Requirements for C'1, C'4, C'2, C'3.补体依赖性免疫吞噬作用。I. 对C'1、C'4、C'2、C'3的需求
Exp Cell Res. 1968 Jul;51(1):45-67. doi: 10.1016/0014-4827(68)90158-4.
5
The demonstration in human serum of "conglutinogen-activating factor" and its effect on the third component of complement.人血清中“胶固素激活因子”的证实及其对补体第三成分的作用。
J Immunol. 1968 Apr;100(4):691-8.
6
C3b inactivator of man. II. Fragments produced by C3b inactivator cleavage of cell-bound or fluid phase C3b.人C3b灭活因子。II. 细胞结合型或液相C3b经C3b灭活因子裂解产生的片段
J Immunol. 1971 Sep;107(3):742-50.
7
Deficiency of C3 inactivator in man.人类C3灭活因子缺乏症。
J Immunol. 1971 Jul;107(1):19-27.
8
Alternate complement pathway: factors involved in cobra venom factor (CoVF) activation of the third component of complement (C3).替代补体途径:参与眼镜蛇毒因子(CoVF)激活补体第三成分(C3)的相关因子。
J Immunol. 1973 Jan;110(1):128-38.
9
The alternate pathway of complement activation. The role of C3 and its inactivator (KAF).补体激活的替代途径。C3及其灭活剂(KAF)的作用。
Immunology. 1973 Feb;24(2):259-75.
10
Properdin factor D. II. Activation to D by properdin.备解素因子D。二、备解素将其激活为D。
J Exp Med. 1974 Aug 1;140(2):426-36. doi: 10.1084/jem.140.2.426.